Ina-Maria Ruckert
Overview
Explore the profile of Ina-Maria Ruckert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruckert I, Baumert J, Schunk M, Holle R, Schipf S, Volzke H, et al.
PLoS One
. 2015 Jul;
10(7):e0133493.
PMID: 26221962
Background: Hypertension is a very common comorbidity and major risk factor for cardiovascular complications, especially in people with Type 2 Diabetes (T2D). Nevertheless, studies in the past have shown that...
2.
Koch M, Baurecht H, Ried J, Rodriguez E, Schlesinger S, Volks N, et al.
J Invest Dermatol
. 2015 Jan;
135(5):1283-1293.
PMID: 25599394
Psoriasis has been linked to cardiometabolic diseases, but epidemiological findings are inconsistent. We investigated the association between psoriasis and cardiometabolic outcomes in a German cross-sectional study (n=4,185) and a prospective...
3.
Baumert J, Meisinger C, Lukaschek K, Emeny R, Ruckert I, Kruse J, et al.
BMC Endocr Disord
. 2014 Nov;
14:87.
PMID: 25416641
Background: Unspecific symptoms often proceed a serious chronic disease condition long before the onset of the disease. The role of an unspecific premonitory symptom (UPMS) pattern as premonitory signs of...
4.
Tamayo T, Claessen H, Ruckert I, Maier W, Schunk M, Meisinger C, et al.
PLoS One
. 2014 Jun;
9(6):e99773.
PMID: 24915157
Background: Diabetes treatment may differ by region and patients' socioeconomic position. This may be particularly true for newer drugs. However, data are highly limited. Methods: We examined pooled individual data...
5.
Laxy M, Mielck A, Hunger M, Schunk M, Meisinger C, Ruckert I, et al.
Diabetes Care
. 2014 Mar;
37(6):1604-12.
PMID: 24667462
Objective: Little is known about the impact of diabetes self-management behavior (SMB) on long-term outcomes. We aimed to examine the association among patient-reported SMB, intermediate clinical outcomes, and mortality in...
6.
Kowall B, Rathmann W, Bongaerts B, Thorand B, Belcredi P, Heier M, et al.
J Diabetes Complications
. 2013 May;
27(4):340-5.
PMID: 23659777
Aim: To evaluate the utility of diabetes prediction models for CVD prediction as stated in two earlier studies. Methods: 845 subjects from the population based German KORA (Cooperative Health Research...
7.
Icks A, Claessen H, Strassburger K, Tepel M, Waldeyer R, Chernyak N, et al.
Diabetes Care
. 2013 Mar;
36(4):e53-4.
PMID: 23520379
No abstract available.
8.
Moller R, Weber Y, Klitten L, Trucks H, Muhle H, Kunz W, et al.
Epilepsia
. 2013 Jan;
54(2):256-64.
PMID: 23294455
Purpose: Neurexins are neuronal adhesion molecules located in the presynaptic terminal, where they interact with postsynaptic neuroligins to form a transsynaptic complex required for efficient neurotransmission in the brain. Recently,...
9.
Ruckert I, Maier W, Mielck A, Schipf S, Volzke H, Kluttig A, et al.
Cardiovasc Diabetol
. 2012 Oct;
11:120.
PMID: 23035799
Background: Hypertension and dyslipidemia are often insufficiently controlled in persons with type 2 diabetes (T2D) in Germany. In the current study we evaluated individual characteristics that are assumed to influence...
10.
Ruckert I, Schunk M, Holle R, Schipf S, Volzke H, Kluttig A, et al.
Cardiovasc Diabetol
. 2012 May;
11:50.
PMID: 22569118
Background: Although most deaths among patients with type 2 diabetes (T2D) are attributable to cardiovascular disease, modifiable cardiovascular risk factors appear to be inadequately treated in medical practice. The aim...